FORG yields 8.62% · JNJ yields 3.36%● Live data
📍 FORG pulled ahead of the other in Year 1
Combined, FORG + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FORG + JNJ for your $10,000?
ForgeRock, Inc., together with its subsidiaries, operates a digital identity platform to secure, manage, and govern the identities of customers, employees, partners, application programing interfaces (APIs), microservices, devices, and the Internet of things worldwide. It offers identity management products to automate onboarding/registration and progressive profiling, identity lifecycle and relationship management, identity provisioning and synchronization, user self-service, personalization, delegation, and privacy and consent management. The company also provides access management products, such as passwordless, usernameless, and multi-factor authentication; single sign-on; contextual and adaptive risk-based access; fine-grained authorization; API and microservices security; and secure impersonation and data sharing. In addition, it offers identity governance products, including access requests that allow users to request access to systems or applications through integration with help desk or service ticketing systems; access reviews and certifications; segregation of duties; role and entitlement management; policy management; identity workflows, which enable enterprises to connect their business processes with identity events; and reporting and analytics. Further, the company provides autonomous identity products that comprise predictive confidence scores for access; overprovisioned access detection and access revocation recommendations; outlier detection; identity automation recommendations; role mining and recommendations; joiner, mover, and leaver access automation; and automated approvals and certifications. ForgeRock, Inc. was founded in 2009 and is headquartered in San Francisco, California.
Full FORG Calculator →Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.